| Pharmaceutical active ingredients: |
| DesogestrelEthinyl Estradiol |
| Available forms, composition and doses of Varnoline Continu: |
| Tablets, Film-Coated; Oral; Desogestrel 0.15 mg; Ethinyl Estradiol 0.03 mg |
| Varnoline Continu medical category: |
| Human:Oestrogens and progesterones and related synthetic drugsOral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA09 - Desogestrel and estrogenG03AB05 - Desogestrel and estrogenG03FB10 - Desogestrel and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| OrganonSchering-Plough |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Solia | Desogestrel; Ethinyl Estradiol | Prasco Laboratories |
| Suavuret | Desogestrel; Ethinyl Estradiol | Organon |
| Tri-Merci | Desogestrel; Ethinyl Estradiol | Organon |
| Trimiron | Desogestrel; Ethinyl Estradiol | Organon; Pharmaco, New Zealand |
| Varnoline | Desogestrel; Ethinyl Estradiol | Organon; Intervet; Schering-Plough |
| Velivet | Desogestrel; Ethinyl Estradiol | Barr Laboratories; Duramed Pharmaceuticals |
| Vilonet | Desogestrel; Ethinyl Estradiol | Wyeth |
| Apolar | Desonide | Alpharma; Actavis |
| Dermades | Desonide | Pharmacore Labs |
| Dermanide | Desonide | Interbat |